Global Gene Therapies for Tumor Treatment Market Growth (Status and Outlook) 2025-2031

December 2025 | 74 pages | ID: G6BA83A5A6CEN
LP Information

Abstracts

According to this study, the global Gene Therapies for Tumor Treatment market size will reach US$ 28700 million by 2031.

Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.

The gene therapies for tumor treatment market is driven by the growing need for targeted and personalized cancer therapies and the increasing focus on innovative treatment approaches. Gene therapies involve the introduction of therapeutic genes into cancer cells to target and destroy tumors or inhibit their growth. The rise in the incidence of cancer and the limitations of conventional cancer treatments contribute to market growth. Moreover, advancements in gene editing technology and the understanding of tumor genetics have improved the development of effective gene therapies. However, the market also faces challenges, including the complexity of tumor heterogeneity and the potential for off-target effects in gene editing. Additionally, addressing regulatory and ethical considerations and ensuring accessibility and affordability can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer safe and efficient gene therapies, collaborate with oncology centers to conduct clinical trials and address specific tumor types, and address the challenges to meet the increasing demand for effective and transformative cancer treatments.

LPI (LP Information)' newest research report, the “Gene Therapies for Tumor Treatment Industry Forecast” looks at past sales and reviews total world Gene Therapies for Tumor Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Therapies for Tumor Treatment sales for 2025 through 2031. With Gene Therapies for Tumor Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapies for Tumor Treatment industry.

This Insight Report provides a comprehensive analysis of the global Gene Therapies for Tumor Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Therapies for Tumor Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapies for Tumor Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapies for Tumor Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapies for Tumor Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapies for Tumor Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Gene Induced Immunotherapy
• Oncolytic Virotherapy
• Gene Transfer

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis
• Gilead Sciences
• Amgen
• Shanghai Sunway
• Sibiono

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Gene Therapies for Tumor Treatment Market Size (2020-2031)
  2.1.2 Gene Therapies for Tumor Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Gene Therapies for Tumor Treatment by Country/Region (2020, 2024 & 2031)
2.2 Gene Therapies for Tumor Treatment Segment by Type
  2.2.1 Gene Induced Immunotherapy
  2.2.2 Oncolytic Virotherapy
  2.2.3 Gene Transfer
2.3 Gene Therapies for Tumor Treatment Market Size by Type
  2.3.1 Gene Therapies for Tumor Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Gene Therapies for Tumor Treatment Market Size Market Share by Type (2020-2025)
2.4 Gene Therapies for Tumor Treatment Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Other
2.5 Gene Therapies for Tumor Treatment Market Size by Application
  2.5.1 Gene Therapies for Tumor Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Gene Therapies for Tumor Treatment Market Size Market Share by Application (2020-2025)

3 GENE THERAPIES FOR TUMOR TREATMENT MARKET SIZE BY PLAYER

3.1 Gene Therapies for Tumor Treatment Market Size Market Share by Player
  3.1.1 Global Gene Therapies for Tumor Treatment Revenue by Player (2020-2025)
  3.1.2 Global Gene Therapies for Tumor Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Gene Therapies for Tumor Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 GENE THERAPIES FOR TUMOR TREATMENT BY REGION

4.1 Gene Therapies for Tumor Treatment Market Size by Region (2020-2025)
4.2 Global Gene Therapies for Tumor Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gene Therapies for Tumor Treatment Market Size Growth (2020-2025)
4.4 APAC Gene Therapies for Tumor Treatment Market Size Growth (2020-2025)
4.5 Europe Gene Therapies for Tumor Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Gene Therapies for Tumor Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Gene Therapies for Tumor Treatment Market Size by Country (2020-2025)
5.2 Americas Gene Therapies for Tumor Treatment Market Size by Type (2020-2025)
5.3 Americas Gene Therapies for Tumor Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Gene Therapies for Tumor Treatment Market Size by Region (2020-2025)
6.2 APAC Gene Therapies for Tumor Treatment Market Size by Type (2020-2025)
6.3 APAC Gene Therapies for Tumor Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Gene Therapies for Tumor Treatment Market Size by Country (2020-2025)
7.2 Europe Gene Therapies for Tumor Treatment Market Size by Type (2020-2025)
7.3 Europe Gene Therapies for Tumor Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Gene Therapies for Tumor Treatment by Region (2020-2025)
8.2 Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL GENE THERAPIES FOR TUMOR TREATMENT MARKET FORECAST

10.1 Global Gene Therapies for Tumor Treatment Forecast by Region (2026-2031)
  10.1.1 Global Gene Therapies for Tumor Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Gene Therapies for Tumor Treatment Forecast
  10.1.3 APAC Gene Therapies for Tumor Treatment Forecast
  10.1.4 Europe Gene Therapies for Tumor Treatment Forecast
  10.1.5 Middle East & Africa Gene Therapies for Tumor Treatment Forecast
10.2 Americas Gene Therapies for Tumor Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Gene Therapies for Tumor Treatment Forecast
  10.2.2 Canada Market Gene Therapies for Tumor Treatment Forecast
  10.2.3 Mexico Market Gene Therapies for Tumor Treatment Forecast
  10.2.4 Brazil Market Gene Therapies for Tumor Treatment Forecast
10.3 APAC Gene Therapies for Tumor Treatment Forecast by Region (2026-2031)
  10.3.1 China Gene Therapies for Tumor Treatment Market Forecast
  10.3.2 Japan Market Gene Therapies for Tumor Treatment Forecast
  10.3.3 Korea Market Gene Therapies for Tumor Treatment Forecast
  10.3.4 Southeast Asia Market Gene Therapies for Tumor Treatment Forecast
  10.3.5 India Market Gene Therapies for Tumor Treatment Forecast
  10.3.6 Australia Market Gene Therapies for Tumor Treatment Forecast
10.4 Europe Gene Therapies for Tumor Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Gene Therapies for Tumor Treatment Forecast
  10.4.2 France Market Gene Therapies for Tumor Treatment Forecast
  10.4.3 UK Market Gene Therapies for Tumor Treatment Forecast
  10.4.4 Italy Market Gene Therapies for Tumor Treatment Forecast
  10.4.5 Russia Market Gene Therapies for Tumor Treatment Forecast
10.5 Middle East & Africa Gene Therapies for Tumor Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Gene Therapies for Tumor Treatment Forecast
  10.5.2 South Africa Market Gene Therapies for Tumor Treatment Forecast
  10.5.3 Israel Market Gene Therapies for Tumor Treatment Forecast
  10.5.4 Turkey Market Gene Therapies for Tumor Treatment Forecast
10.6 Global Gene Therapies for Tumor Treatment Forecast by Type (2026-2031)
10.7 Global Gene Therapies for Tumor Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Gene Therapies for Tumor Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novartis
  11.1.1 Novartis Company Information
  11.1.2 Novartis Gene Therapies for Tumor Treatment Product Offered
  11.1.3 Novartis Gene Therapies for Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Novartis Main Business Overview
  11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
  11.2.1 Gilead Sciences Company Information
  11.2.2 Gilead Sciences Gene Therapies for Tumor Treatment Product Offered
  11.2.3 Gilead Sciences Gene Therapies for Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Gilead Sciences Main Business Overview
  11.2.5 Gilead Sciences Latest Developments
11.3 Amgen
  11.3.1 Amgen Company Information
  11.3.2 Amgen Gene Therapies for Tumor Treatment Product Offered
  11.3.3 Amgen Gene Therapies for Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Amgen Main Business Overview
  11.3.5 Amgen Latest Developments
11.4 Shanghai Sunway
  11.4.1 Shanghai Sunway Company Information
  11.4.2 Shanghai Sunway Gene Therapies for Tumor Treatment Product Offered
  11.4.3 Shanghai Sunway Gene Therapies for Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Shanghai Sunway Main Business Overview
  11.4.5 Shanghai Sunway Latest Developments
11.5 Sibiono
  11.5.1 Sibiono Company Information
  11.5.2 Sibiono Gene Therapies for Tumor Treatment Product Offered
  11.5.3 Sibiono Gene Therapies for Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Sibiono Main Business Overview
  11.5.5 Sibiono Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Gene Therapies for Tumor Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gene Therapies for Tumor Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Gene Induced Immunotherapy
Table 4. Major Players of Oncolytic Virotherapy
Table 5. Major Players of Gene Transfer
Table 6. Gene Therapies for Tumor Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Gene Therapies for Tumor Treatment Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Gene Therapies for Tumor Treatment Market Size Market Share by Type (2020-2025)
Table 9. Gene Therapies for Tumor Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Gene Therapies for Tumor Treatment Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Gene Therapies for Tumor Treatment Market Size Market Share by Application (2020-2025)
Table 12. Global Gene Therapies for Tumor Treatment Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Gene Therapies for Tumor Treatment Revenue Market Share by Player (2020-2025)
Table 14. Gene Therapies for Tumor Treatment Key Players Head office and Products Offered
Table 15. Gene Therapies for Tumor Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Gene Therapies for Tumor Treatment Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Gene Therapies for Tumor Treatment Market Size Market Share by Region (2020-2025)
Table 20. Global Gene Therapies for Tumor Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Gene Therapies for Tumor Treatment Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Gene Therapies for Tumor Treatment Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Gene Therapies for Tumor Treatment Market Size Market Share by Country (2020-2025)
Table 24. Americas Gene Therapies for Tumor Treatment Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Gene Therapies for Tumor Treatment Market Size Market Share by Type (2020-2025)
Table 26. Americas Gene Therapies for Tumor Treatment Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Gene Therapies for Tumor Treatment Market Size Market Share by Application (2020-2025)
Table 28. APAC Gene Therapies for Tumor Treatment Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Gene Therapies for Tumor Treatment Market Size Market Share by Region (2020-2025)
Table 30. APAC Gene Therapies for Tumor Treatment Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Gene Therapies for Tumor Treatment Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Gene Therapies for Tumor Treatment Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Gene Therapies for Tumor Treatment Market Size Market Share by Country (2020-2025)
Table 34. Europe Gene Therapies for Tumor Treatment Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Gene Therapies for Tumor Treatment Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Gene Therapies for Tumor Treatment
Table 40. Key Market Challenges & Risks of Gene Therapies for Tumor Treatment
Table 41. Key Industry Trends of Gene Therapies for Tumor Treatment
Table 42. Global Gene Therapies for Tumor Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Gene Therapies for Tumor Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Gene Therapies for Tumor Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Gene Therapies for Tumor Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Novartis Details, Company Type, Gene Therapies for Tumor Treatment Area Served and Its Competitors
Table 47. Novartis Gene Therapies for Tumor Treatment Product Offered
Table 48. Novartis Gene Therapies for Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Novartis Main Business
Table 50. Novartis Latest Developments
Table 51. Gilead Sciences Details, Company Type, Gene Therapies for Tumor Treatment Area Served and Its Competitors
Table 52. Gilead Sciences Gene Therapies for Tumor Treatment Product Offered
Table 53. Gilead Sciences Gene Therapies for Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Gilead Sciences Main Business
Table 55. Gilead Sciences Latest Developments
Table 56. Amgen Details, Company Type, Gene Therapies for Tumor Treatment Area Served and Its Competitors
Table 57. Amgen Gene Therapies for Tumor Treatment Product Offered
Table 58. Amgen Gene Therapies for Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Amgen Main Business
Table 60. Amgen Latest Developments
Table 61. Shanghai Sunway Details, Company Type, Gene Therapies for Tumor Treatment Area Served and Its Competitors
Table 62. Shanghai Sunway Gene Therapies for Tumor Treatment Product Offered
Table 63. Shanghai Sunway Gene Therapies for Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Shanghai Sunway Main Business
Table 65. Shanghai Sunway Latest Developments
Table 66. Sibiono Details, Company Type, Gene Therapies for Tumor Treatment Area Served and Its Competitors
Table 67. Sibiono Gene Therapies for Tumor Treatment Product Offered
Table 68. Sibiono Gene Therapies for Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Sibiono Main Business
Table 70. Sibiono Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Gene Therapies for Tumor Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapies for Tumor Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gene Therapies for Tumor Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gene Therapies for Tumor Treatment Sales Market Share by Country/Region (2024)
Figure 8. Gene Therapies for Tumor Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gene Therapies for Tumor Treatment Market Size Market Share by Type in 2024
Figure 10. Gene Therapies for Tumor Treatment in Hospital
Figure 11. Global Gene Therapies for Tumor Treatment Market: Hospital (2020-2025) & ($ millions)
Figure 12. Gene Therapies for Tumor Treatment in Clinic
Figure 13. Global Gene Therapies for Tumor Treatment Market: Clinic (2020-2025) & ($ millions)
Figure 14. Gene Therapies for Tumor Treatment in Other
Figure 15. Global Gene Therapies for Tumor Treatment Market: Other (2020-2025) & ($ millions)
Figure 16. Global Gene Therapies for Tumor Treatment Market Size Market Share by Application in 2024
Figure 17. Global Gene Therapies for Tumor Treatment Revenue Market Share by Player in 2024
Figure 18. Global Gene Therapies for Tumor Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Gene Therapies for Tumor Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Gene Therapies for Tumor Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Gene Therapies for Tumor Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Gene Therapies for Tumor Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Gene Therapies for Tumor Treatment Value Market Share by Country in 2024
Figure 24. United States Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Gene Therapies for Tumor Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Gene Therapies for Tumor Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Gene Therapies for Tumor Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Gene Therapies for Tumor Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Gene Therapies for Tumor Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Gene Therapies for Tumor Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Gene Therapies for Tumor Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Gene Therapies for Tumor Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Gene Therapies for Tumor Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Gene Therapies for Tumor Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Gene Therapies for Tumor Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Gene Therapies for Tumor Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Gene Therapies for Tumor Treatment Market Size 2026-2031 ($ millions)